Primary information |
---|
ID | 17163 |
Uniprot ID | P02763 |
Description | Alpha-1-acid glycoprotein 1 (AGP 1) (Orosomucoid-1) (OMD 1) |
Organism | Homo sapiens |
Txonomy | Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata (jawed vertebrates); Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Mammalia; Theria; Eutheria; Boreoeutheria; Euarchontoglires; Primates; Haplorrhini; Simiiformes; Catarrhini; Hominoidea (apes); Hominidae (great apes); Homininae; Homo; Homo sapiens (Human) |
Subcellular Location | Secreted |
Developmental Stage | NA |
Similarity | NA |
Tissue Specificity | Expressed by the liver and secreted in plasma. |
Post Translational Modification | N-glycosylated. N-glycan heterogeneity at Asn-33- Hex5HexNAc4 (minor); Hex6HexNAc5 (major) and dHex1Hex6HexNAc5 (minor). |
Function | Functions as transport protein in the blood stream. Binds various ligands in the interior of its beta-barrel domain. Also binds synthetic drugs and influences their distribution and availability in the body. Appears to function in modulating the activity of the immune system during the acute-phase reaction. |
Length | 201 |
Molecular Weight | 23540 |
Name | Alpha-1-acid glycoprotein 1 |
Sequence | IPLCANLVPVPITNATLDRITGKWFYIASAFRNEEYNKSVQEIQATFFYFTPNKTEDTIFLREYQTRQDQCIYNTTYLNVQRENGTISRYVGGQEHFAHLLILRDTKTYMLAFDVNDEKNWGLSVYADKPETTKEQLGEFYEALDCLRIPKSDVVYTDWKKDKCEPLEKQHEKERKQEEGES |
Sequence map | 22-21 |
PDB ID | NA |
Drugpedia | NA |
Receptor | P51681 |
Domain | Contains a beta-barrel that binds various ligands |
Pharmaceutical Use | NA
|